Maxcyte (MXCT) Inventory (2020 - 2026)

Maxcyte (MXCT) has 7 years of Inventory data on file, last reported at $7.6 million in Q1 2026.

• Inventory for Q1 2026 came in at $7.6 million, down 7.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.6 million (down 7.77% YoY), and the FY2025 annual result was $7.5 million, down 15.34% from the prior year.
• Inventory grew to $7.6 million in Q1 2026 per MXCT's latest filing, from $7.5 million in the prior quarter.
• Over five years, Inventory peaked at $12.5 million in Q3 2023 and troughed at $6.6 million in Q1 2022.
• A 5-year average of $9.3 million and a median of $8.6 million in 2022 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2025: Inventory surged 90.71% in 2022, then slumped 30.82% in 2025.
• A 5-year view of Inventory shows it stood at $8.6 million in 2022, then jumped by 42.51% to $12.2 million in 2023, then slipped by 27.11% to $8.9 million in 2024, then declined by 15.34% to $7.5 million in 2025, then increased by 1.11% to $7.6 million in 2026.
• Business Quant data shows MXCT's Inventory at $7.6 million in Q1 2026, $7.5 million in Q4 2025, and $7.6 million in Q3 2025.